| EPB033 | Tolerability of Isoniazid and 3HP among opioid dependent people in a Malaysian prison | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB034 | Incidence and risk factors for liver enzyme elevation in HIV-1 infected patients treated for tuberculosis: a secondary analysis of the multi-country ANRS 12300 REFLATE TB2 trial | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB035 | Early culture conversion among people with HIV and drug resistant tuberculosis in Uganda | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB036 | Evaluating two tuberculosis preventive therapy treatment modalities in an HIV treatment program: 3HP versus 6H | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB037 | Traditional healers are 'part & parcel' on fight against TB'. Lesson learnt, Ruvuma region, Tanzania | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB038 | Integration of TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB case detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in Harare City, Zimbabwe | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB039 | Safety and pharmacokinetic of daily isoniazid/rifapentine (1HP) in adults with HIV on standard dose of dolutegravir | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB040 | Treatment outcome of rifampicin-resistant tuberculosis among people with HIV in South Africa: a nested prospective cohort study | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB041 | Clinical and virologic outcomes of TB/HIV co-infected patients treated with dolutegravir-based HIV antiretroviral regimens: programmatic experience from Nigeria | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB042 | Identifying gaps in the tuberculosis care cascade in sub-Saharan Africa | E-poster | Tuberculosis: Prevention, diagnosis, treatment |